Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

NCT02717195 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1098

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Risperidone
DRUG: Olanzapine
DRUG: Lu AF35700
DRUG: Lu AF35700

Sponsor

H. Lundbeck A/S